Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003670 |
---|---|
Receipt number | R000004449 |
Scientific Title | A Randomized Phase II/III Trial of Tri-weekly Intravenous versus Tri-weekly Intraperitoneal Carboplatin Both in Combination with Weekly Intravenous Paclitaxel for Newly Diagnosed Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer |
Date of disclosure of the study information | 2010/06/01 |
Last modified on | 2023/10/06 16:02:30 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/05/28 12:37:11 | ||
2 | Update | 2010/11/29 14:05:24 | Email |
|
3 | Update | 2010/12/28 10:17:53 | Institutions |
|
4 | Update | 2011/05/31 10:00:55 | Institutions |
|
5 | Update | 2011/11/30 08:29:15 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
6 | Update | 2011/12/28 10:55:22 | Key exclusion criteria Key exclusion criteria |
|
7 | Update | 2011/12/28 10:57:42 | Anticipated trial start date Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
8 | Update | 2011/12/28 11:23:46 | Division name |
|
9 | Update | 2012/05/11 08:01:35 | Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
10 | Update | 2012/05/28 11:15:43 | Institutions |
|
11 | Update | 2012/05/28 11:22:06 | URL releasing protocol |
|
12 | Update | 2012/12/28 10:18:10 | Institutions |
|
13 | Update | 2013/05/28 15:26:20 | Target sample size |
|
14 | Update | 2013/05/28 15:34:51 | TEL Organization Organization Division name Division name Address Address TEL |
|
15 | Update | 2013/05/28 15:47:18 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
16 | Update | 2013/05/28 16:00:18 | Division name Division name Institute |
|
17 | Update | 2013/05/28 16:16:20 | Organization Organization Division name Division name Address |
|
18 | Update | 2013/05/28 16:28:04 | Name of secondary funder(s) |
|
19 | Update | 2013/11/28 14:59:44 | Email |
|
20 | Update | 2014/01/08 12:26:18 | Institutions |
|
21 | Update | 2014/05/29 09:41:51 | Institutions |
|
22 | Update | 2015/05/28 12:20:37 | Name of person sending information Name of person sending information |
|
23 | Update | 2015/05/28 12:28:57 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
24 | Update | 2015/07/03 17:59:41 | Institutions |
|
25 | Update | 2016/05/12 16:09:38 | Region |
|
26 | Update | 2016/05/12 16:28:42 | Name of primary person or sponsor Organization Category of Funding Organization |
|
27 | Update | 2016/05/12 16:30:53 | Institutions |
|
28 | Update | 2016/06/07 11:21:32 | Email1 Institutions |
|
29 | Update | 2016/08/17 11:05:29 | Recruitment status |
|
30 | Update | 2017/06/01 09:41:18 | Organization Organization |
|
31 | Update | 2017/06/01 10:01:32 | Randomization unit Target sample size |
|
32 | Update | 2017/12/04 11:22:13 | Name of person sending information Nationality of Funding Organization Nationality of Funding Organization Institutions |
|
33 | Update | 2018/06/04 11:15:05 | Institutions |
|
34 | Update | 2018/09/27 12:33:18 | Division name Division name |
|
35 | Update | 2018/10/09 10:20:40 | Institutions |
|
36 | Update | 2018/10/10 14:40:46 | Name of person sending information Name of person sending information |
|
37 | Update | 2019/06/03 15:17:59 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Organization1 Address1 Tel1 Email1 Organization Organization Address Address Tel Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 Study ID_2 Org. issuing International ID_2 Org. issuing International ID_2 |
|
38 | Update | 2019/06/03 15:18:44 | Number of participants that the trial has enrolled |
|
39 | Update | 2019/06/03 15:22:45 | Date of IRB Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
40 | Update | 2019/06/05 11:11:07 | Date of IRB |
|
41 | Update | 2019/12/03 16:27:23 | Institutions |
|
42 | Update | 2019/12/04 11:37:41 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
43 | Update | 2020/12/04 11:30:40 | Date trial data considered complete |
|
44 | Update | 2021/06/10 06:12:06 | Institute Institute Name of secondary funder(s) |
|
45 | Update | 2021/12/06 11:50:26 | Organization Organization Division name Division name Zip code Address Address TEL |
|
46 | Update | 2021/12/06 11:50:26 | Organization Organization Division name Division name Zip code Address Address TEL |
|
47 | Update | 2023/10/06 14:45:08 | Recruitment status |
|
48 | Update | 2023/10/06 15:20:56 | Recruitment status |
|
49 | Update | 2023/10/06 16:02:30 | Recruitment status |